Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936932 · ClinicalTrials.gov registry record · NA
Laser Treatment of Basal Cell Carcinoma
A NA study, sponsored by Sciton.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04936932: Completed NA study, sponsored by Sciton.
NCT04936932 is a NA study that has completed, run by Sciton. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04936932, a NA study, has completed, sponsored by Sciton.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Laser treatment of Basal cell carcinoma
Primary Outcome
Histological confirmation of BCC clearance. Biopsy will be taken from the treatment site to confirm complete BCC clearance
Interventions
- DEVICE 1064 nm long-pulse Nd:YAG laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2022-08-20 |
| Phase | NA |
What the finished NCT04936932 record still lists
NCT04936932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which 1064 nm long-pulse Nd:YAG laser is the first listed.
NCT04936932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04936932 about?
NCT04936932 is a clinical study titled "Laser Treatment of Basal Cell Carcinoma". Laser treatment of Basal cell carcinoma
What is the current status of trial NCT04936932?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2021-11-01. Estimated completion is 2022-08-20.
What interventions are being tested in trial NCT04936932?
The interventions under investigation include: 1064 nm long-pulse Nd:YAG laser (DEVICE).
Who is sponsoring clinical trial NCT04936932?
This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04936932's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI